Pricing Log in Create free account

Biofrontera Inc. (BFRI) vs Optimi Health Corp. (OPTH)

Biofrontera Inc. and Optimi Health Corp. are both Drug Manufacturers Specialty & Generic companies. Optimi Health Corp. is the larger, with a market value of $13.7M against $12.0M — 1.1× the size. Across the 8 metrics below, Biofrontera Inc. leads on 4 and Optimi Health Corp. on 4.

Valuation

Metric BFRI OPTH Drug Manufacturers Specialty & Generic median
P/E n/m — 20.55
P/S 0.23 n/m 2.08
P/B 1.78 2.86 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 0.23 n/m 2.87
Earnings yield (72.84%) — (15.94%)
Free cash flow yield (74.83%) (66.34%) 0.00%

Profitability

Metric BFRI OPTH Drug Manufacturers Specialty & Generic median
Gross margin 79.25% — 53.51%
Operating margin (14.22%) — 0.00%
Net margin (13.78%) — (2.45%)
Free cash flow margin (17.17%) 0.00% 0.00%
Return on equity (988.35%) — (0.80%)
Return on assets (28.80%) — (1.67%)
Return on invested capital (69.45%) 0.00% 0.00%

Growth

Metric BFRI OPTH Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 17.83% — 5.22%
EPS growth (last fiscal year) 67.70% (1,575.96%) 42.91%
Revenue growth, 5-year CAGR 17.21% — 7.24%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BFRI OPTH Drug Manufacturers Specialty & Generic median
Debt to equity 0.78 1.02 0.04
Current ratio 1.18 0.06 2.41
Net debt to EBITDA 0.17 (0.67) 1.01

Dividend

Metric BFRI OPTH Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric BFRI OPTH Drug Manufacturers Specialty & Generic median
Market cap 11.99m 13.69m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack